TherapeuticsMD

TXMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$23.959 M

$2.07 -0.96%

Close of 7 Aug 2026

Revenue

$1.76M

#3454 by revenue

Earnings

-$569.0K

Loss-making

Shares outstanding

11,574,362

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#386Barinthus BiotherapeuticsBRNS$24.5M
#387LongeveronLGVN$24.2M
#388TherapeuticsMDTXMD$24.0M
#389Tvardi TherapeuticsTVRD$23.3M
#390Quantum BiopharmaQNTM$22.1M

Where these numbers come from

Share counts and financials for TherapeuticsMD are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.